Indonesia · Delayed Price · Currency is IDR PT Medikaloka Hermina Tbk Statistics
Total Valuation
IDX:HEAL has a market cap or net worth of IDR 7.85 trillion. The enterprise value is 12.51 trillion.
| Market Cap | 7.85T |
| Enterprise Value | 12.51T |
Important Dates
The next estimated earnings date is Thursday, October 29, 2026.
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | May 5, 2026 |
Share Statistics
IDX:HEAL has 15.25 billion shares outstanding. The number of shares has increased by 2.03% in one year.
| Current Share Class | 15.25B |
| Shares Outstanding | 15.25B |
| Shares Change (YoY) | +2.03% |
| Shares Change (QoQ) | -0.10% |
| Owned by Insiders (%) | 26.93% |
| Owned by Institutions (%) | 2.80% |
| Float | 7.93B |
Valuation Ratios
The trailing PE ratio is 20.92 and the forward PE ratio is 15.45. IDX:HEAL's PEG ratio is 1.09.
| PE Ratio | 20.92 |
| Forward PE | 15.45 |
| PS Ratio | 1.07 |
| PB Ratio | 1.09 |
| P/TBV Ratio | 1.40 |
| P/FCF Ratio | 196.99 |
| P/OCF Ratio | 5.50 |
| PEG Ratio | 1.09 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.90, with an EV/FCF ratio of 313.92.
| EV / Earnings | 33.20 |
| EV / Sales | 1.70 |
| EV / EBITDA | 6.90 |
| EV / EBIT | 13.81 |
| EV / FCF | 313.92 |
Financial Position
The company has a current ratio of 1.17, with a Debt / Equity ratio of 0.51.
| Current Ratio | 1.17 |
| Quick Ratio | 1.08 |
| Debt / Equity | 0.51 |
| Debt / EBITDA | 2.04 |
| Debt / FCF | 92.68 |
| Interest Coverage | 3.90 |
Financial Efficiency
Return on equity (ROE) is 6.82% and return on invested capital (ROIC) is 6.31%.
| Return on Equity (ROE) | 6.82% |
| Return on Assets (ROA) | 4.70% |
| Return on Invested Capital (ROIC) | 6.31% |
| Return on Capital Employed (ROCE) | 8.80% |
| Weighted Average Cost of Capital (WACC) | 3.61% |
| Revenue Per Employee | 383.08M |
| Profits Per Employee | 19.59M |
| Employee Count | 19,235 |
| Asset Turnover | 0.61 |
| Inventory Turnover | 39.46 |
Taxes
In the past 12 months, IDX:HEAL has paid 198.64 billion in taxes.
| Income Tax | 198.64B |
| Effective Tax Rate | 28.92% |
Stock Price Statistics
The stock price has decreased by -65.67% in the last 52 weeks. The beta is -0.19, so IDX:HEAL's price volatility has been lower than the market average.
| Beta (5Y) | -0.19 |
| 52-Week Price Change | -65.67% |
| 50-Day Moving Average | 617.48 |
| 200-Day Moving Average | 977.97 |
| Relative Strength Index (RSI) | 37.56 |
| Average Volume (20 Days) | 9,765,395 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IDX:HEAL had revenue of IDR 7.37 trillion and earned 376.85 billion in profits. Earnings per share was 24.62.
| Revenue | 7.37T |
| Gross Profit | 2.46T |
| Operating Income | 906.26B |
| Pretax Income | 686.87B |
| Net Income | 376.85B |
| EBITDA | 1.81T |
| EBIT | 906.26B |
| Earnings Per Share (EPS) | 24.62 |
Balance Sheet
The company has 628.77 billion in cash and 3.69 trillion in debt, with a net cash position of -3,065.31 billion or -201.06 per share.
| Cash & Cash Equivalents | 628.77B |
| Total Debt | 3.69T |
| Net Cash | -3,065.31B |
| Net Cash Per Share | -201.06 |
| Equity (Book Value) | 7.19T |
| Book Value Per Share | 366.76 |
| Working Capital | 334.20B |
Cash Flow
In the last 12 months, operating cash flow was 1.43 trillion and capital expenditures -1,387.85 billion, giving a free cash flow of 39.86 billion.
| Operating Cash Flow | 1.43T |
| Capital Expenditures | -1,387.85B |
| Depreciation & Amortization | 905.20B |
| Net Borrowing | 242.59B |
| Free Cash Flow | 39.86B |
| FCF Per Share | 2.61 |
Margins
Gross margin is 33.33%, with operating and profit margins of 12.30% and 5.11%.
| Gross Margin | 33.33% |
| Operating Margin | 12.30% |
| Pretax Margin | 9.32% |
| Profit Margin | 5.11% |
| EBITDA Margin | 24.58% |
| EBIT Margin | 12.30% |
| FCF Margin | 0.54% |
Dividends & Yields
This stock pays an annual dividend of 10.50, which amounts to a dividend yield of 2.04%.
| Dividend Per Share | 10.50 |
| Dividend Yield | 2.04% |
| Dividend Growth (YoY) | 28.57% |
| Years of Dividend Growth | 6 |
| Payout Ratio | 54.62% |
| FCF Payout Ratio | n/a |
| Buyback Yield | -2.03% |
| Shareholder Yield | 0.01% |
| Earnings Yield | 4.78% |
| FCF Yield | 0.51% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for IDX:HEAL is 1,273.93, which is 147.37% higher than the current price. The consensus rating is "Buy".
| Price Target | 1,273.93 |
| Price Target Difference | 147.37% |
| Analyst Consensus | Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (3Y) | 9.06% |
| EPS Growth Forecast (3Y) | 13.62% |
Stock Splits
The last stock split was on July 30, 2021. It was a forward split with a ratio of 5.
| Last Split Date | Jul 30, 2021 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |